Cannabis Apps: What are the Must-Have Downloads?
March 9th, 2016
Policy, Top News, Top Story
Mobile apps are used for everything from keeping up with friends to making online purchases these days. With the legalization of medical and recreational cannabis in several states, many users have turned to cannabis apps to find strains and dispensaries. WeedMaps, MassRoots, and Leafly have quickly become staples on the stoner’s smartphone, but there are many other apps that cannabis enthusiasts may also want to consider downloading.
Weedmaps is a community where medical marijuana patients can connect with other patients in their region to discuss and review local cannabis coops, dispensaries, doctors, and delivery services. The service started off as the cannabis industry’s version of Yelp and expanded to include a deals section that’s similar to Groupon. Looking ahead, the company has plans to introduce an online shop that could make it even easier to access marijuana.
MassRoots is a social network that connects cannabis enthusiasts in a 420-friendly community where like-minded people can freely share their experiences. The service is often considered to be the “Facebook of cannabis” with the added ability to keep up with dispensaries and track deals in the space. With its friendly and open user base, the app is a great way to meet likeminded individuals in any place where the drug has been legalized.
Leafly is a leading resource for information about cannabis strains. With thousands of marijuana strains in its database, users can analyze the effects of these strains and find nearby dispensaries that carry them for medical or recreational usage. Users can review these strains based on their desired effects and flavors and the app aggregates this data into highly-useful information that can help people obtain the experiences they’re looking for.
MyDx – short for My Diagnostic – is focused on helping consumers analyze the cannabis that they consume. While the app has a companion device, users can also use the standalone app to record their favorite strains and see what effects they might have for users. The app is similar in some ways to Leafly, but the MyDx team’s extensive chemistry know-how provides a more detailed chemical analysis of the cannabinoids present in given strains.
The MyDx analyzer takes the app a step further by making it easy to analyze a specific cannabis sample for things like THC and CBD content. By leveraging its expertise in chemical analysis, the company’s technology “smells” a cannabis sample to determine these components with an increasing level of accuracy. The device is available for $699 and includes everything you need to get a Total Canna Profile™ of cannabinoid and terpene content.
PotBot is a medical marijuana recommendation engine that guides patients to the appropriate cannabinoid levels, medical cannabis strains, and consumption methods for specific ailments. Once a personalized recommendation is in place, the app connects patients with nearby dispensaries and sets up an appointment. The app employs a robust database of strains that are aggregated, compiled, and curated, as well as validated through an EEG/EKG.
The company is a subsidiary of PotBiotics Inc., which specializes in developing cannabis-focused technologies for everyone from cultivators to consumers.
Website / Desktop App: www.potbot.com
iOS App: Coming Soon
Android App: Coming Soon
Cannacopia solves the confusion of what cannabis strains to purchase and where to purchase them from. For instance, users can search for strains that make them feel energetic, rejuvenated, relaxed, or sleepy, while filtering for tastes that range from sweet to spicy. The app even shows users a picture of each strain to compare what’s available at a dispensary to the actual strain that’s photographed within the app.
Doobster is a HIPPA-compliant mobile app and platform that enables medical marijuana patients and adult recreational users to order products from their smartphone or tablet. With 4-tap access to a product of their choice from a dispensary of their choice, these users can have the drug delivered in minutes by vetted drivers. The app also provides a pick-up option for those simply looking to avoid the long lines at dispensaries.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.